glp-1 telehealth crackdown news today FEDS CRACK DOWN ON COMPANIES SELLING GLP-1s: The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight Drug ad enforcement ramps up–again

Brain-specific tyrosine phosphatase, STEP (STriatal-Enriched protein tyrosine Phosphatase) together with STEP61, a membrane-associated phosphatase found in the postsynaptic density, are important regulators of synaptic function [15, 115]

Jones L, Cleator J, Yorke J

study likely suffered from detection bias and confounding by obesity, as patients taking GLP-1s tend to see their doctors more frequently, leading to higher detection rates of slow-growing thyroid nodules

Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors